Seattle Genetics | SGEN - Zapasy



Zapasy Zmiana Data
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Amgen USD 6.22B 34M 2026-06
Astellas Pharma JPY 331.01B 33.75B 2026-03
Bayer EUR 11.97B 43M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Daiichi Sankyo JPY 692.38B 83.83B 2026-03
Eisai JPY 257.55B 21.09B 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Exelixis USD 28.73M 2.12M 2026-06
Genmab DKK 21M 8M 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
Incyte USD 112.54M 3.08M 2026-06
Insmed USD 142.38M 9.48M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.21B 272M 2026-06
Moderna USD 280M 134M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.22B 66M 2026-06
Pfizer USD 9.94B 722M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Sanofi EUR 24.12B 620M 2026-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Takeda JPY 1.45T 50.64B 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06